Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
170,107,714
-
Total 13F shares
-
119,547,665
-
Share change
-
+4,508,409
-
Total reported value
-
$4,109,936,889
-
Put/Call ratio
-
148%
-
Price per share
-
$34.38
-
Number of holders
-
215
-
Value change
-
+$169,511,200
-
Number of buys
-
114
-
Number of sells
-
100
Institutional Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) as of Q1 2017
As of 31 Mar 2017,
ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) was held by
215 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
119,547,665 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., OppenheimerFunds, Inc., PRICE T ROWE ASSOCIATES INC /MD/, FRANKLIN RESOURCES INC, JANUS CAPITAL MANAGEMENT LLC, STATE STREET CORP, and WADDELL & REED FINANCIAL INC.
This page lists
215
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.